Abiopharma

🔍 WEHRWEIN SVEN (Director)

Company: AtriCure, Inc. (ATRC)

Report Date: 2025-08-22

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Stock at $19.95 per share (Direct)
  Date: 2025-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 39,374.00 | transaction_form_type: 4
• Sold 5,000 shares of Common Stock at $37.0 per share (Direct)
  Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 34,374.00 | transaction_form_type: 4
• Sold 5,000 shares of Non-qualified Stock Option (right to buy) at $19.95 per share (Derivative)
  Date: 2025-08-22 | Code: M | Expires: 2026-11-11 | Exercise: 2017-11-11 | equity_swap_involved: 0 | shares_owned_after: 35,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.